These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 22052346)

  • 1. Are prions part of the dark matter of the cell?
    Baudin-Baillieu A; Fabret C; Namy O
    Prion; 2011; 5(4):299-304. PubMed ID: 22052346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unraveling infectious structures, strain variants and species barriers for the yeast prion [PSI+].
    Tessier PM; Lindquist S
    Nat Struct Mol Biol; 2009 Jun; 16(6):598-605. PubMed ID: 19491937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic control of polyamines by the prion [PSI+].
    Namy O; Galopier A; Martini C; Matsufuji S; Fabret C; Rousset JP
    Nat Cell Biol; 2008 Sep; 10(9):1069-75. PubMed ID: 19160487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The physical dimensions of amyloid aggregates control their infective potential as prion particles.
    Marchante R; Beal DM; Koloteva-Levine N; Purton TJ; Tuite MF; Xue WF
    Elife; 2017 Sep; 6():. PubMed ID: 28880146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radically different amyloid conformations dictate the seeding specificity of a chimeric Sup35 prion.
    Foo CK; Ohhashi Y; Kelly MJ; Tanaka M; Weissman JS
    J Mol Biol; 2011 Apr; 408(1):1-8. PubMed ID: 21333653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analyzing the birth and propagation of two distinct prions, [PSI+] and [Het-s](y), in yeast.
    Mathur V; Taneja V; Sun Y; Liebman SW
    Mol Biol Cell; 2010 May; 21(9):1449-61. PubMed ID: 20219972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly(A)-binding protein acts in translation termination via eukaryotic release factor 3 interaction and does not influence [PSI(+)] propagation.
    Cosson B; Couturier A; Chabelskaya S; Kiktev D; Inge-Vechtomov S; Philippe M; Zhouravleva G
    Mol Cell Biol; 2002 May; 22(10):3301-15. PubMed ID: 11971964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [PSI(+) ] prion variant establishment in yeast.
    Sharma J; Liebman SW
    Mol Microbiol; 2012 Nov; 86(4):866-81. PubMed ID: 22998111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prion amyloid structure explains templating: how proteins can be genes.
    Wickner RB; Shewmaker F; Edskes H; Kryndushkin D; Nemecek J; McGlinchey R; Bateman D; Winchester CL
    FEMS Yeast Res; 2010 Dec; 10(8):980-91. PubMed ID: 20726897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guanidine hydrochloride blocks a critical step in the propagation of the prion-like determinant [PSI(+)] of Saccharomyces cerevisiae.
    Eaglestone SS; Ruddock LW; Cox BS; Tuite MF
    Proc Natl Acad Sci U S A; 2000 Jan; 97(1):240-4. PubMed ID: 10618402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic study of interactions between the cytoskeletal assembly protein sla1 and prion-forming domain of the release factor Sup35 (eRF3) in Saccharomyces cerevisiae.
    Bailleul PA; Newnam GP; Steenbergen JN; Chernoff YO
    Genetics; 1999 Sep; 153(1):81-94. PubMed ID: 10471702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteolysis suppresses spontaneous prion generation in yeast.
    Okamoto A; Hosoda N; Tanaka A; Newnam GP; Chernoff YO; Hoshino SI
    J Biol Chem; 2017 Dec; 292(49):20113-20124. PubMed ID: 29038292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Origins and kinetic consequences of diversity in Sup35 yeast prion fibers.
    DePace AH; Weissman JS
    Nat Struct Biol; 2002 May; 9(5):389-96. PubMed ID: 11938354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Yeast prions, mammalian amyloidoses, and the problem of proteomic networks].
    Galkin AP; Mironova LN; Zhuravleva GA; Inge-Vechtomov SG
    Genetika; 2006 Nov; 42(11):1558-70. PubMed ID: 17163073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A bipolar personality of yeast prion proteins.
    Kurahashi H; Oishi K; Nakamura Y
    Prion; 2011; 5(4):305-10. PubMed ID: 22156730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yeast Prions Compared to Functional Prions and Amyloids.
    Wickner RB; Edskes HK; Son M; Bezsonov EE; DeWilde M; Ducatez M
    J Mol Biol; 2018 Oct; 430(20):3707-3719. PubMed ID: 29698650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new colour assay for [URE3] prion in a genetic background used to score for the [PSI⁺] prion.
    Hong JY; Mathur V; Liebman SW
    Yeast; 2011 Jul; 28(7):555-60. PubMed ID: 21590810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular basis for transmission barrier and interference between closely related prion proteins in yeast.
    Afanasieva EG; Kushnirov VV; Tuite MF; Ter-Avanesyan MD
    J Biol Chem; 2011 May; 286(18):15773-80. PubMed ID: 21454674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chaperones that cure yeast artificial [PSI+] and their prion-specific effects.
    Kushnirov VV; Kryndushkin DS; Boguta M; Smirnov VN; Ter-Avanesyan MD
    Curr Biol; 2000 Nov; 10(22):1443-6. PubMed ID: 11102806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yeast prions form infectious amyloid inclusion bodies in bacteria.
    Espargaró A; Villar-Piqué A; Sabaté R; Ventura S
    Microb Cell Fact; 2012 Jun; 11():89. PubMed ID: 22731490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.